| Devin Arthur Oller, MD | |
|
830 S. Limestone, Uk Division Of General Internal Medicine, Lexington, KY 40536 | |
| (859) 323-0303 | |
| (859) 323-1200 |
| Full Name | Devin Arthur Oller |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 11 Years |
| Location | 830 S. Limestone, Lexington, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023351897 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RA0401X | Internal Medicine - Addiction Medicine | 51551 (Kentucky) | Secondary |
| 207R00000X | Internal Medicine | 51551 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Kentucky Hospital | Lexington, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kentucky Medical Services Foundation, Inc | 5698689909 | 806 |
News Archive
In September, patients suffering from multiple sclerosis (MS) received the welcome news that the U.S. Food and Drug Administration (FDA) had approved a promising new drug for their condition called Gilenya. Now, a team from The Scripps Research Institute has discovered that this drug's success may involve an unexpected biological mechanism acting within the central nervous system (CNS). This difference may mean that Gilenya offers even more benefits than previously realized and would represent the first MS therapy with direct CNS activities.
Brain & Behavior Research Foundation will honor five outstanding researchers at the Annual Klerman and Freedman Awards event in New York City.
For decades, metformin has been the first-line drug in the treatment of type 2 diabetes, lowering blood glucose levels by inhibiting glucose production in the liver. Metformin also improves glucose uptake and use by muscle tissue.
A new poll from the Kaiser Family Foundation has found that most of the public wants deficit reduction, but they want it without cutting major social programs like Medicare and Medicaid. On health care, the public favors requiring drug makers to give the government 'a better deal' on medications for low-income seniors and making higher-income seniors pay more for coverage to reduce the deficit. Kaiser Health News is an editorially independent program of the Foundation.
› Verified 6 days ago
| Entity Name | Kentucky Medical Services Foundation, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326091448 PECOS PAC ID: 5698689909 Enrollment ID: O20031119000300 |
News Archive
In September, patients suffering from multiple sclerosis (MS) received the welcome news that the U.S. Food and Drug Administration (FDA) had approved a promising new drug for their condition called Gilenya. Now, a team from The Scripps Research Institute has discovered that this drug's success may involve an unexpected biological mechanism acting within the central nervous system (CNS). This difference may mean that Gilenya offers even more benefits than previously realized and would represent the first MS therapy with direct CNS activities.
Brain & Behavior Research Foundation will honor five outstanding researchers at the Annual Klerman and Freedman Awards event in New York City.
For decades, metformin has been the first-line drug in the treatment of type 2 diabetes, lowering blood glucose levels by inhibiting glucose production in the liver. Metformin also improves glucose uptake and use by muscle tissue.
A new poll from the Kaiser Family Foundation has found that most of the public wants deficit reduction, but they want it without cutting major social programs like Medicare and Medicaid. On health care, the public favors requiring drug makers to give the government 'a better deal' on medications for low-income seniors and making higher-income seniors pay more for coverage to reduce the deficit. Kaiser Health News is an editorially independent program of the Foundation.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Devin Arthur Oller, MD 900 S. Limestone, Ctw306, Uk Division Of General Internal Medicine, Lexington, KY 40536 Ph: () - | Devin Arthur Oller, MD 830 S. Limestone, Uk Division Of General Internal Medicine, Lexington, KY 40536 Ph: (859) 323-0303 |
News Archive
In September, patients suffering from multiple sclerosis (MS) received the welcome news that the U.S. Food and Drug Administration (FDA) had approved a promising new drug for their condition called Gilenya. Now, a team from The Scripps Research Institute has discovered that this drug's success may involve an unexpected biological mechanism acting within the central nervous system (CNS). This difference may mean that Gilenya offers even more benefits than previously realized and would represent the first MS therapy with direct CNS activities.
Brain & Behavior Research Foundation will honor five outstanding researchers at the Annual Klerman and Freedman Awards event in New York City.
For decades, metformin has been the first-line drug in the treatment of type 2 diabetes, lowering blood glucose levels by inhibiting glucose production in the liver. Metformin also improves glucose uptake and use by muscle tissue.
A new poll from the Kaiser Family Foundation has found that most of the public wants deficit reduction, but they want it without cutting major social programs like Medicare and Medicaid. On health care, the public favors requiring drug makers to give the government 'a better deal' on medications for low-income seniors and making higher-income seniors pay more for coverage to reduce the deficit. Kaiser Health News is an editorially independent program of the Foundation.
› Verified 6 days ago
Mr. Fabrizio Canepa Escaro, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: Uk Division Of Hospital Medicine 800 Rose, Lexington, KY 40536 Phone: 859-323-6047 Fax: 859-257-3873 | |
Dr. Moneera Nur Haque, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 125 E Maxwell St Ste 200, Lexington, KY 40508 Phone: 859-323-3231 Fax: 859-257-9461 | |
Dr. Indhira Bisono Jimenez, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 211 Fountain Ct, Suite 220, Lexington, KY 40509 Phone: 859-629-7265 Fax: 859-629-7266 | |
Deepali Pandey, MBBS Internal Medicine Medicare: Medicare Enrolled Practice Location: 800 Rose St # Cc-402, Lexington, KY 40536 Phone: 650-804-3111 | |
Dr. Dorothy Mccord Maes, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1000 S Limestone, Lexington, KY 40536 Phone: 859-323-9057 Fax: 859-323-9502 | |
Dr. Stephen M Mooney, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2101 Nicholasville Rd Ste 304, Lexington, KY 40503 Phone: 859-277-5771 Fax: 859-276-4622 | |
Michael Han Young, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 740 S Limestone, Lexington, KY 40536 Phone: 859-323-5544 Fax: 859-257-9286 |